SCHEMBL524900

SCHEMBL524900

CCOP(=O)(CCCl)OCC

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 2/20 0.58
TSHR P16473 2/20 0.55
TP53 P04637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27321475 0.86 TSHR (0.46) PPARDTSHRTP53TDP1ALDH1A1
SCHEMBL11441759 0.85 PPARD (0.54) PPARDTSHRTP53TDP1
SCHEMBL5017294 0.83 PPARD (0.64) PPARDTSHRTP53TDP1
SCHEMBL8656736 0.83 PPARD (0.52) PPARDTSHRTP53TDP1
SCHEMBL3313657 0.83 PPARD (0.70) PPARDTSHRTP53TDP1
SCHEMBL11663291 0.78 TSHR (0.39) PPARDTSHRTP53TDP1
SCHEMBL7268189 0.78 PPARD (0.64) PPARDTSHRTP53TDP1
SCHEMBL248038 0.78 PPARD (0.64) PPARDTSHRTP53TDP1
SCHEMBL431806 0.78 TSHR (0.60) PPARDTSHRTP53TDP1ALDH1A1
SCHEMBL11796292 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118206842-B Composite material based on modified heavy calcium carbonate and application thereof 湖南佰裕科技股份有限公司 2024-10-18 CN claimed
CN-118206842-A Composite material based on modified heavy calcium carbonate and application thereof 湖南佰裕科技股份有限公司 2024-06-18 CN claimed
EP-4570977-A1 METHOD OF DYEING A TOUCH FASTENER STRIP Gottlieb Binder GmbH & Co. KG (DE) 2025-06-18 EP disclosed
CN-119491423-A Method for dyeing sticking buckle belt 戈特利布捆扎机械有限及两合公司 2025-02-21 CN disclosed
US-20250059706-A1 METHOD FOR DYEING A HOOK-AND-LOOP FASTENER STRAP GOTTLIEB BINDER GMBH & CO. KG (DE) 2025-02-20 US disclosed
EP-3576743-B1 5-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-5-AZASPIRO[2 5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS JAK KINASE INHIBITORS LEO PHARMA AS (DK) 2023-01-18 EP disclosed
CN-108135175-A Bicyclic compounds and their use for inhibition of SUV39H2 肿瘤疗法科学股份有限公司 2018-06-08 CN disclosed
EP-2598509-B1 METHOD OF THE SYNTHESIS OF DIETHYL OR DIISOPROPYL HALOALKYLPHOSPHONATES AND DIETHYL OR DIISOPROPYL HALOALKYLOXYALKYLPHOSPHONATES ÚSTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY V V I (CZ) 2018-02-07 EP disclosed
EP-2598509-A1 METHOD OF THE SYNTHESIS OF DIALKYL HALOALKYLPHOSPHONATES AND DIALKYL HALOALKYLOXYALKYLPHOSPHONATES Ustav Organicke Chemie a Biochemie Akademie Ved Ceske Republiky, V.V.I. (CZ) 2013-06-05 EP disclosed
WO-2012013168-A1 METHOD OF THE SYNTHESIS OF DIALKYL HALOALKYLPHOSPHONATES AND DIALKYL HALOALKYLOXYALKYLPHOSPHONATES ÚSTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY, v.v.i. (CZ) 2012-02-02 WO disclosed
US-20070190523-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2007-08-16 US disclosed
US-20020082447-A1 Process for preparing ethylenediphosphonic acids CLARIANT GMBH 2002-06-27 US disclosed
US-5965539-A PEPTIDOMIMETICS; ANTI-CANCER DRUGS UNIVERISTY OF PITTSBURGH (US) 1999-10-12 US disclosed
EP-0794789-A4 INHIBITORS OF PRENYL TRANSFERASES UNIV PITTSBURGH (US) 1999-05-26 EP disclosed
US-5856310-A ANTITUMOR AGENTS UNIVERSITY OF PITTSBURGH (US) 1999-01-05 US disclosed
US-5834434-A PEPTIDOMIMETICS UNIVERSITY OF PITTSBURGH (US) 1998-11-10 US disclosed
EP-0794789-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1997-09-17 EP disclosed
US-5602098-A ANTICANCER AGENT UNIVERSITY OF PITTSBURGH (US) 1997-02-11 US disclosed
WO-1996021456-A1 INHIBITORS OF PRENYL TRANSFERASES UNIVERSITY OF PITTSBURGH (US) 1996-07-18 WO disclosed
US-4293505-A Preparation of β-haloethylphosphonic acids and half esters thereof GAF CHEMICALS CORPORATION 1981-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020082447-A1 Process for preparing ethylenediphosphonic acids ENPP1, ALK, INPPL1 PPARD 4450/4885TSHR 3992/4885TP53 3538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.